Management of Elderly Male with CKD Stage 4 and COVID-19

Immediate Assessment and Monitoring

The British Medical Journal recommends measuring serum urea, creatinine, and electrolytes at least every 48 hours or more frequently if clinically indicated, as acute-on-chronic kidney injury dramatically increases mortality risk in CKD patients with COVID-19 2
The Pharmacological Research journal suggests monitoring coagulation parameters closely, particularly D-dimer levels, which are significantly elevated in elderly COVID-19 patients and indicate higher risk of disseminated intravascular coagulation 3
The British Medical Journal advises tracking fluid status daily through clinical examination and fluid balance 2

The American College of Physicians, as summarized by Praxis Medical Insights, recommends administering dexamethasone 6 mg daily for 10 days, which reduces all-cause mortality by 3% and decreases mechanical ventilation requirements 1
The American College of Physicians, as summarized by Praxis Medical Insights, suggests adding tocilizumab or sarilumab if IL-6 or CRP ≥100 mg/L, as this reduces mortality particularly at higher CRP levels 1
The American College of Physicians, as summarized by Praxis Medical Insights, advises avoiding corticosteroids before oxygen requirement is established, as early use in the viral phase worsens outcomes and delays viral clearance 1

The National Kidney Foundation, as summarized by Praxis Medical Insights, recommends systematically reducing all medication doses: patients 60-80 years should receive 3/4 to 4/5 of standard adult doses; those over 80 years require 1/2 of adult doses due to deteriorated hepatic and renal clearance 1
The European Renal Association, as summarized by Pharmacological Research, suggests reviewing all prescriptions to minimize polypharmacy and prevent drug-drug interactions, using medications with the lowest risk of interactions at minimum effective doses for shortest duration 3, 1
The British Medical Journal recommends maintaining optimal fluid status, as this is critical in reducing AKI incidence 2

The British Medical Journal advises referring for specialist advice if diagnostic uncertainty exists about AKI cause, abnormal urinalysis results suggesting COVID-19-induced kidney damage, complex fluid management needs, or AKI worsening despite initial management or not resolved after 48 hours 2
The British Medical Journal suggests referring if usual indications for renal replacement therapy develop, particularly with no urine output 2
The British Medical Journal notes that 31% of COVID-19 patients on ventilators and 4% not on ventilators require renal replacement therapy for AKI 2

The American College of Physicians, as summarized by Praxis Medical Insights, advises not using corticosteroids too early, as this worsens outcomes 1
The Pharmacological Research journal suggests not overlooking secondary bacterial infections, which occur more frequently in elderly patients 3, 1
The American College of Physicians, as summarized by Praxis Medical Insights, recommends not failing to adjust medication doses for age and renal function, as elderly patients have significantly higher risk of adverse events and organ damage 1